These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

374 related items for PubMed ID: 28968865

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A prospective cohort study of 14-3-3η in ACPA and/or RF-positive patients with arthralgia.
    van Beers-Tas MH, Marotta A, Boers M, Maksymowych WP, van Schaardenburg D.
    Arthritis Res Ther; 2016 Apr 01; 18():76. PubMed ID: 27037016
    [Abstract] [Full Text] [Related]

  • 6. Does information on novel identified autoantibodies contribute to predicting the progression from undifferentiated arthritis to rheumatoid arthritis: a study on anti-CarP antibodies as an example.
    Boeters DM, Trouw LA, van der Helm-van Mil AHM, van Steenbergen HW.
    Arthritis Res Ther; 2018 May 03; 20(1):94. PubMed ID: 29724250
    [Abstract] [Full Text] [Related]

  • 7. MRI-detected osteitis is not associated with the presence or level of ACPA alone, but with the combined presence of ACPA and RF.
    Boeters DM, Nieuwenhuis WP, Verheul MK, Newsum EC, Reijnierse M, Toes RE, Trouw LA, van der Helm-van Mil AH.
    Arthritis Res Ther; 2016 Aug 02; 18():179. PubMed ID: 27485323
    [Abstract] [Full Text] [Related]

  • 8. Arthritis development in patients with arthralgia is strongly associated with anti-citrullinated protein antibody status: a prospective cohort study.
    Bos WH, Wolbink GJ, Boers M, Tijhuis GJ, de Vries N, van der Horst-Bruinsma IE, Tak PP, van de Stadt RJ, van der Laken CJ, Dijkmans BA, van Schaardenburg D.
    Ann Rheum Dis; 2010 Mar 02; 69(3):490-4. PubMed ID: 19363023
    [Abstract] [Full Text] [Related]

  • 9. Clinical factors, anticitrullinated peptide antibodies and MRI-detected subclinical inflammation in relation to progression from clinically suspect arthralgia to arthritis.
    van Steenbergen HW, Mangnus L, Reijnierse M, Huizinga TW, van der Helm-van Mil AH.
    Ann Rheum Dis; 2016 Oct 02; 75(10):1824-30. PubMed ID: 26613769
    [Abstract] [Full Text] [Related]

  • 10. The association between anti-carbamylated protein (anti-CarP) antibodies and radiographic progression in early rheumatoid arthritis: a study exploring replication and the added value to ACPA and rheumatoid factor.
    Ajeganova S, van Steenbergen HW, Verheul MK, Forslind K, Hafström I, Toes RE, Huizinga TW, Svensson B, Trouw LA, van der Helm-van Mil AH.
    Ann Rheum Dis; 2017 Jan 02; 76(1):112-118. PubMed ID: 27117699
    [Abstract] [Full Text] [Related]

  • 11. Diagnostic utility of, and influence of tobacco usage and genetic predisposition on, immunoglobulin A, rheumatoid factor and anti-citrullinated peptide auto-antibodies in South African rheumatoid arthritis patients.
    Meyer P, Ally M, Hodkinson B, Anderson R, Tikly M.
    Afr Health Sci; 2018 Jun 02; 18(2):295-303. PubMed ID: 30602956
    [Abstract] [Full Text] [Related]

  • 12. Smoking is associated with the concurrent presence of multiple autoantibodies in rheumatoid arthritis rather than with anti-citrullinated protein antibodies per se: a multicenter cohort study.
    van Wesemael TJ, Ajeganova S, Humphreys J, Terao C, Muhammad A, Symmons DP, MacGregor AJ, Hafström I, Trouw LA, van der Helm-van Mil AH, Huizinga TW, Mimori T, Toes RE, Matsuda F, Svensson B, Verstappen SM, van der Woude D.
    Arthritis Res Ther; 2016 Dec 01; 18(1):285. PubMed ID: 27906045
    [Abstract] [Full Text] [Related]

  • 13. Differences in the symptomatic phase preceding ACPA-positive and ACPA-negative RA: a longitudinal study in arthralgia during progression to clinical arthritis.
    Burgers LE, van Steenbergen HW, Ten Brinck RM, Huizinga TW, van der Helm-van Mil AH.
    Ann Rheum Dis; 2017 Oct 01; 76(10):1751-1754. PubMed ID: 28606964
    [Abstract] [Full Text] [Related]

  • 14. EULAR definition of "arthralgia suspicious for progression to rheumatoid arthritis" in a large cohort of patients included in a program for rapid diagnosis: role of auto-antibodies and ultrasound.
    Ruta S, Prado ES, Chichande JT, Ruta A, Salvatori F, Magri S, Salinas RG.
    Clin Rheumatol; 2020 May 01; 39(5):1493-1499. PubMed ID: 31933033
    [Abstract] [Full Text] [Related]

  • 15. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
    van der Linden MP, van der Woude D, Ioan-Facsinay A, Levarht EW, Stoeken-Rijsbergen G, Huizinga TW, Toes RE, van der Helm-van Mil AH.
    Arthritis Rheum; 2009 Aug 01; 60(8):2232-41. PubMed ID: 19644872
    [Abstract] [Full Text] [Related]

  • 16. Inflammation functions as a key mediator in the link between ACPA and erosion development: an association study in Clinically Suspect Arthralgia.
    Ten Brinck RM, Toes REM, van der Helm-van Mil AHM.
    Arthritis Res Ther; 2018 May 03; 20(1):89. PubMed ID: 29720256
    [Abstract] [Full Text] [Related]

  • 17. Presence of autoantibodies in "seronegative" rheumatoid arthritis associates with classical risk factors and high disease activity.
    Reed E, Hedström AK, Hansson M, Mathsson-Alm L, Brynedal B, Saevarsdottir S, Cornillet M, Jakobsson PJ, Holmdahl R, Skriner K, Serre G, Alfredsson L, Rönnelid J, Lundberg K.
    Arthritis Res Ther; 2020 Jul 16; 22(1):170. PubMed ID: 32678001
    [Abstract] [Full Text] [Related]

  • 18. Patient burden and joint inflammation during development of RA from arthralgia: is it similar in ACPA-positive and ACPA-negative disease?
    Khidir SJH, Krijbolder DI, Glas HK, van Mulligen E, van der Helm-van Mil AHM.
    Rheumatology (Oxford); 2024 Sep 01; 63(9):2336-2344. PubMed ID: 38261628
    [Abstract] [Full Text] [Related]

  • 19. Association of the Presence of Anti-Carbamylated Protein Antibodies in Early Arthritis With a Poorer Clinical and Radiologic Outcome: Data From the French ESPOIR Cohort.
    Truchetet ME, Dublanc S, Barnetche T, Vittecoq O, Mariette X, Richez C, Blanco P, Mahler M, Contin-Bordes C, Schaeverbeke T, Fédération Hospitalo-Universitaire ACRONIM.
    Arthritis Rheumatol; 2017 Dec 01; 69(12):2292-2302. PubMed ID: 28853240
    [Abstract] [Full Text] [Related]

  • 20. Anticarbamylated protein antibodies are associated with long-term disability and increased disease activity in patients with early inflammatory arthritis: results from the Norfolk Arthritis Register.
    Humphreys JH, Verheul MK, Barton A, MacGregor AJ, Lunt M, Toes RE, Symmons DP, Trouw LA, Verstappen SM.
    Ann Rheum Dis; 2016 Jun 01; 75(6):1139-44. PubMed ID: 26443608
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.